View Financial HealthCryosite 배당 및 자사주 매입배당 기준 점검 0/6Cryosite 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률2.4%자사주 매입 수익률총 주주 수익률2.4%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트분석 기사 • Aug 22Cryosite (ASX:CTE) Is Due To Pay A Dividend Of A$0.02Cryosite Limited ( ASX:CTE ) has announced that it will pay a dividend of A$0.02 per share on the 10th of October. This...Declared Dividend • Aug 22Final dividend of AU$0.02 announcedShareholders will receive a dividend of AU$0.02. Ex-date: 6th September 2024 Payment date: 10th October 2024 Dividend yield will be 8.8%, which is higher than the industry average of 0.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share has grown by 14% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Upcoming Dividend • Feb 14Upcoming dividend of AU$0.05 per share at 2.2% yieldEligible shareholders must have bought the stock before 21 February 2024. Payment date: 29 February 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (0.5%).Upcoming Dividend • Aug 31Upcoming dividend of AU$0.015 per share at 1.5% yieldEligible shareholders must have bought the stock before 07 September 2023. Payment date: 06 October 2023. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Australian dividend payers (7.0%). Higher than average of industry peers (0.5%).공시 • Aug 25Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023Cryosite Limited announced dividend of AUD 0.01500000 per share for the twelve months ended June 30, 2023. Record date is September 8, 2023. Ex-date is September 7, 2023. Payment date is October 6, 2023.Upcoming Dividend • Sep 08Upcoming dividend of AU$0.01 per shareEligible shareholders must have bought the stock before 15 September 2022. Payment date: 14 October 2022. Trailing yield: 1.4%. Lower than top quartile of Australian dividend payers (6.6%). Higher than average of industry peers (0.4%).모든 업데이트 보기Recent updates분석 기사 • Jun 01Cryosite (ASX:CTE) Ticks All The Boxes When It Comes To Earnings GrowthFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Reported Earnings • Mar 03First half 2026 earnings released: EPS: AU$0.023 (vs AU$0.017 in 1H 2025)First half 2026 results: EPS: AU$0.023 (up from AU$0.017 in 1H 2025). Revenue: AU$8.27m (up 25% from 1H 2025). Net income: AU$1.14m (up 36% from 1H 2025). Profit margin: 14% (up from 13% in 1H 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.New Risk • Feb 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 114% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks High level of debt (114% net debt to equity). Market cap is less than US$100m (AU$58.8m market cap, or US$41.9m).분석 기사 • Feb 09Cryosite Limited's (ASX:CTE) Price Is Out Of Tune With EarningsWith a price-to-earnings (or "P/E") ratio of 31.2x Cryosite Limited ( ASX:CTE ) may be sending very bearish signals at...Board Change • Jan 13No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Board Change • Dec 11No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improves as stock rises 28%After last week's 28% share price gain to AU$1.30, the stock trades at a trailing P/E ratio of 33.7x. Average trailing P/E is 36x in the Life Sciences industry globally. Total returns to shareholders of 125% over the past three years.Board Change • Sep 18No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Reported Earnings • Aug 22Full year 2025 earnings released: EPS: AU$0.039 (vs AU$0.038 in FY 2024)Full year 2025 results: EPS: AU$0.039 (up from AU$0.038 in FY 2024). Revenue: AU$14.1m (up 12% from FY 2024). Net income: AU$1.88m (up 2.4% from FY 2024). Profit margin: 13% (down from 15% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.분석 기사 • Aug 19Cryosite Limited's (ASX:CTE) Share Price Could Signal Some RiskASX:CTE 1 Year Share Price vs Fair Value Explore Cryosite's Fair Values from the Community and select yours It's not a...공시 • Aug 18Cryosite Limited, Annual General Meeting, Oct 16, 2025Cryosite Limited, Annual General Meeting, Oct 16, 2025. Location: at the thomson geer offices, at level 23, rialto south tower, 525 collins street, melbourne vic 3004 AustraliaRecent Insider Transactions • Jul 02Non-Executive Chairman recently bought AU$56k worth of stockOn the 27th of June, Mark Kerr bought around 75k shares on-market at roughly AU$0.74 per share. This transaction amounted to 1.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Mark's only on-market trade for the last 12 months.Board Change • Jun 23No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Board Change • Mar 17No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Reported Earnings • Feb 24First half 2025 earnings released: EPS: AU$0.017 (vs AU$0.017 in 1H 2024)First half 2025 results: EPS: AU$0.017 (in line with 1H 2024). Revenue: AU$6.64m (up 3.7% from 1H 2024). Net income: AU$838.0k (flat on 1H 2024). Profit margin: 13% (in line with 1H 2024). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Jan 15Cryosite Limited's (ASX:CTE) Subdued P/E Might Signal An OpportunityThere wouldn't be many who think Cryosite Limited's ( ASX:CTE ) price-to-earnings (or "P/E") ratio of 19.1x is worth a...공시 • Nov 22Cryosite Limited Announces Resignation of Michael Austin as Joint Company SecretaryCryosite Limited announced that Mr. Michael Austin has resigned as Joint Company Secretary, effective 22 November 2024. Mr. Hamish George of Bio101 Financial Advisory Pty Ltd. remains as Company Secretary and is responsible for communications with the ASX in relation to Listing Rule matters under ASX Listing Rule 12.6.공시 • Oct 21Cryosite Limited, Annual General Meeting, Nov 22, 2024Cryosite Limited, Annual General Meeting, Nov 22, 2024. Location: boardroom, level 2 90 william st, melbourne,vic, 3000., melbourne, Australia공시 • Sep 20Cryosite Limited Announces Company Secretary ChangesCryosite Limited announced that Hamish George and Michael Austin of Bio101 Financial Advisory Pty Ltd. (Bio101) have been appointed Joint Company Secretaries of the Company. The appointment follows the resignation of Mr. Dray Andrea as Company Secretary, effective 20 September 2024. The Board would like to thank Mr. Andrea for his service in the role of Company Secretary.분석 기사 • Aug 22Cryosite (ASX:CTE) Is Due To Pay A Dividend Of A$0.02Cryosite Limited ( ASX:CTE ) has announced that it will pay a dividend of A$0.02 per share on the 10th of October. This...Declared Dividend • Aug 22Final dividend of AU$0.02 announcedShareholders will receive a dividend of AU$0.02. Ex-date: 6th September 2024 Payment date: 10th October 2024 Dividend yield will be 8.8%, which is higher than the industry average of 0.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share has grown by 14% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Aug 21Full year 2024 earnings released: EPS: AU$0.038 (vs AU$0.029 in FY 2023)Full year 2024 results: EPS: AU$0.038 (up from AU$0.029 in FY 2023). Revenue: AU$12.6m (up 5.7% from FY 2023). Net income: AU$1.84m (up 31% from FY 2023). Profit margin: 15% (up from 12% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year and the company’s share price has also increased by 22% per year.분석 기사 • Aug 20With A 31% Price Drop For Cryosite Limited (ASX:CTE) You'll Still Get What You Pay ForCryosite Limited ( ASX:CTE ) shares have had a horrible month, losing 31% after a relatively good period beforehand...공시 • Aug 20+ 2 more updatesCryosite Limited Announces Retirement of John Hogg as Chief Executive Officer, Effective October 31, 2024Cryosite announced the retirement of its Chief Executive Officer, Mr. John Hogg, with effect from October 31, 2024. The Board thanks Mr. Hogg for his support and service to the Board and the Company over his tenure.Buy Or Sell Opportunity • Jul 26Now 20% undervaluedOver the last 90 days, the stock has risen 14% to AU$0.97. The fair value is estimated to be AU$1.22, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.5% over the last 3 years. Earnings per share has grown by 29%.분석 기사 • Jul 23Calculating The Intrinsic Value Of Cryosite Limited (ASX:CTE)Key Insights The projected fair value for Cryosite is AU$1.21 based on 2 Stage Free Cash Flow to Equity With AU$0.98...New Risk • Jun 26New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: AU$8.2m This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Significant insider selling over the past 3 months (AU$8.2m sold). Market cap is less than US$100m (AU$56.1m market cap, or US$37.5m).공시 • Jun 25Cryosite Limited Announces Retirement of Andrew Kroger from the Board of DirectorsCryosite Limited announced that Andrew Kroger has retired from the board of directors (Board) effective from June 25, 2024.Valuation Update With 7 Day Price Move • May 24Investor sentiment improves as stock rises 24%After last week's 24% share price gain to AU$1.05, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 32x in the Life Sciences industry globally. Total returns to shareholders of 238% over the past three years.분석 기사 • May 09Cryosite Limited's (ASX:CTE) 33% Jump Shows Its Popularity With InvestorsThe Cryosite Limited ( ASX:CTE ) share price has done very well over the last month, posting an excellent gain of 33...Recent Insider Transactions • Apr 27Non Executive Director recently sold AU$830k worth of stockOn the 23rd of April, Andrew Kroger sold around 1m shares on-market at roughly AU$0.83 per share. This transaction amounted to 7.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.공시 • Feb 22Cryosite Limited Announces Board ChangesCryosite Limited announced the appointment of Mr. Andrew Kerr as a Director of the Company. Mr. John Hogg will step down as Managing Director and continue in his current executive position as CEO of Cryosite. Andrew is an experienced financial services professional in both the Australian and international markets. Andrew is a qualified Certified Practising Accountant (CPA) and a graduate of the Australian Institute of Company Directors (GAICD) course. Through his roles at Bank of America Merrill Lynch and Macquarie Bank, Andrew has obtained strong sustainability and ESG credentials which will greatly complement the Board.Upcoming Dividend • Feb 14Upcoming dividend of AU$0.05 per share at 2.2% yieldEligible shareholders must have bought the stock before 21 February 2024. Payment date: 29 February 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (0.5%).분석 기사 • Feb 02Subdued Growth No Barrier To Cryosite Limited's (ASX:CTE) PriceWhen close to half the companies in Australia have price-to-earnings ratios (or "P/E's") below 18x, you may consider...Board Change • Dec 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Dec 08Cryosite Limited Announces Director ChangesCryosite Limited announced the appointment of Mr. Mark Kerr, as a new Director and Chairman. Mr. John Hogg, CEO of Cryosite will also join the Board as the Managing Director. The only variation to Mr. Hogg's employment agreement is to reflect his new office with the Company. The company announced the retirement from the Board of Directors of Steven Waller, Nicola Swift and Luis Antonio. The Board thanks the three retiring directors for their outstanding contribution to the Company over a number of years. The retiring directors have contributed substantial hours beyond what was expected to ensure the success of the Company going forward.공시 • Oct 02Cryosite Limited, Annual General Meeting, Nov 23, 2023Cryosite Limited, Annual General Meeting, Nov 23, 2023, at 11:01 AUS Eastern Standard Time. Location: The offices of Cryosite, 13A Ferndell St, South Granville New South Wales AustraliaUpcoming Dividend • Aug 31Upcoming dividend of AU$0.015 per share at 1.5% yieldEligible shareholders must have bought the stock before 07 September 2023. Payment date: 06 October 2023. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Australian dividend payers (7.0%). Higher than average of industry peers (0.5%).공시 • Aug 25Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023Cryosite Limited announced dividend of AUD 0.01500000 per share for the twelve months ended June 30, 2023. Record date is September 8, 2023. Ex-date is September 7, 2023. Payment date is October 6, 2023.Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$0.014 (vs AU$0.016 in 1H 2022)First half 2023 results: EPS: AU$0.014 (down from AU$0.016 in 1H 2022). Revenue: AU$5.72m (down 1.7% from 1H 2022). Net income: AU$678.7k (down 13% from 1H 2022). Profit margin: 12% (down from 13% in 1H 2022). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 150% per year, which means it is well ahead of earnings.분석 기사 • Feb 07Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...공시 • Jan 20Cryosite Limited Announces Change of Company SecretaryCryosite Limited announces the resignation of Kim Bradley-Ware and the appointment of Dray Andrea as Company Secretary, both effective January 18, 2023.Recent Insider Transactions • Jan 18Insider recently bought AU$481k worth of stockOn the 13th of January, Mark Kerr bought around 650k shares on-market at roughly AU$0.74 per share. This transaction amounted to 39% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$582k. Insiders have collectively bought AU$2.6m more in shares than they have sold in the last 12 months.Recent Insider Transactions • Dec 26Insider recently bought AU$582k worth of stockOn the 19th of December, Mark Kerr bought around 885k shares on-market at roughly AU$0.66 per share. This transaction amounted to 79% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$2.1m more in shares than they have sold in the last 12 months.Recent Insider Transactions • Oct 14Insider recently bought AU$447k worth of stockOn the 11th of October, Mark Kerr bought around 600k shares on-market at roughly AU$0.74 per share. This transaction amounted to 63% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$1.6m more in shares than they have sold in the last 12 months.공시 • Sep 21Cryosite Limited, Annual General Meeting, Nov 17, 2022Cryosite Limited, Annual General Meeting, Nov 17, 2022, at 10:00 E. Australia Standard Time. Location: at the offices of Stone & Chalk, Level 4, 11 York Street, Sydney NSW 2000 Sydney Nsw 2000 AustraliaUpcoming Dividend • Sep 08Upcoming dividend of AU$0.01 per shareEligible shareholders must have bought the stock before 15 September 2022. Payment date: 14 October 2022. Trailing yield: 1.4%. Lower than top quartile of Australian dividend payers (6.6%). Higher than average of industry peers (0.4%).공시 • Aug 26Cryosite Limited Announces Ordinary Dividend for the Year Ended June 30, 2022, Payable on October 14, 2022Cryosite Limited announced ordinary dividend of AUD 0.01000000 for the year ended June 30, 2022. Record Date is September 16, 2022. Ex Date is September 15, 2022. Payment Date is October 14, 2022.Reported Earnings • Aug 26Full year 2022 earnings released: EPS: AU$0.028 (vs AU$0.014 in FY 2021)Full year 2022 results: EPS: AU$0.028 (up from AU$0.014 in FY 2021). Revenue: AU$11.8m (up 17% from FY 2021). Net income: AU$1.36m (up 109% from FY 2021). Profit margin: 12% (up from 6.5% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 136% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Aug 19Should You Be Adding Cryosite (ASX:CTE) To Your Watchlist Today?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...분석 기사 • May 02Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Mar 03Non Executive Director recently bought AU$321k worth of stockOn the 28th of February, Andrew Kroger bought around 716k shares on-market at roughly AU$0.45 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$931k more in shares than they have sold in the last 12 months.Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.016 (up from AU$0.006 in 1H 2021). Revenue: AU$5.82m (up 19% from 1H 2021). Net income: AU$782.4k (up 175% from 1H 2021). Profit margin: 13% (up from 5.8% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has increased by 119% per year, which means it is tracking significantly ahead of earnings growth.Recent Insider Transactions Derivative • Sep 09Key Executive exercised options to buy AU$546k worth of stock.On the 6th of September, Bryan Dulhunty exercised options to buy 1m shares at a strike price of around AU$0.06, costing a total of AU$78k. This transaction amounted to 4,333% of their direct individual holding at the time of the trade. Bryan currently holds less than 1% of total shares outstanding. Company insiders have collectively bought AU$687k more than they sold, via options and on-market transactions, in the last 12 months.Reported Earnings • Aug 26Full year 2021 earnings released: EPS AU$0.014 (vs AU$0.032 in FY 2020)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: AU$10.1m (up 12% from FY 2020). Net income: AU$652.6k (down 56% from FY 2020). Profit margin: 6.5% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has increased by 91% per year, which means it is tracking significantly ahead of earnings growth.Recent Insider Transactions • Jun 11Non Executive Director recently bought AU$170k worth of stockOn the 8th of June, Andrew Kroger bought around 473k shares on-market at roughly AU$0.36 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$173k more in shares than they have sold in the last 12 months.Is New 90 Day High Low • Feb 17New 90-day low: AU$0.21The company is down 25% from its price of AU$0.28 on 18 November 2020. The Australian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is up 11% over the same period.Is New 90 Day High Low • Dec 21New 90-day high: AU$0.36The company is up 59% from its price of AU$0.23 on 22 September 2020. The Australian market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is down 2.0% over the same period.Is New 90 Day High Low • Nov 12New 90-day high: AU$0.30The company is up 76% from its price of AU$0.17 on 14 August 2020. The Australian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is down 12% over the same period.공시 • Oct 15+ 1 more updateCryosite Limited Announces the Appointment of John Hogg as Chief Executive OfficerCryosite Limited announced the appointment of Mr. John Hogg as Chief Executive Officer of the Company commencing October 15, 2020. Mr. Hogg joined Cryosite in July 2018 and was promoted to General Manager of Operations on the December 1, 2019. He has deployed his skills and experience in Australia, Asia and the US. Mr. Hogg has qualifications in materials management, freight management, accounting and computing, including European Senior Logistician (ESLog) certification, and he is a Chartered Member of The Chartered Institute of Logistics and Transport (CMILT).Is New 90 Day High Low • Oct 08New 90-day high: AU$0.24The company is up 71% from its price of AU$0.14 on 10 July 2020. The Australian market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is down 2.0% over the same period.Is New 90 Day High Low • Sep 18New 90-day high: AU$0.21The company is up 65% from its price of AU$0.13 on 18 June 2020. The Australian market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is up 11% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 CTE 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: CTE 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Cryosite 배당 수익률 vs 시장CTE의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (CTE)0%시장 하위 25% (AU)2.7%시장 상위 25% (AU)6.8%업계 평균 (Life Sciences)2.3%분석가 예측 (CTE) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 CTE 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 CTE 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: CTE Australian 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: CTE 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YAU 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/15 17:58종가2026/06/15 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Cryosite Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
분석 기사 • Aug 22Cryosite (ASX:CTE) Is Due To Pay A Dividend Of A$0.02Cryosite Limited ( ASX:CTE ) has announced that it will pay a dividend of A$0.02 per share on the 10th of October. This...
Declared Dividend • Aug 22Final dividend of AU$0.02 announcedShareholders will receive a dividend of AU$0.02. Ex-date: 6th September 2024 Payment date: 10th October 2024 Dividend yield will be 8.8%, which is higher than the industry average of 0.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share has grown by 14% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Upcoming Dividend • Feb 14Upcoming dividend of AU$0.05 per share at 2.2% yieldEligible shareholders must have bought the stock before 21 February 2024. Payment date: 29 February 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (0.5%).
Upcoming Dividend • Aug 31Upcoming dividend of AU$0.015 per share at 1.5% yieldEligible shareholders must have bought the stock before 07 September 2023. Payment date: 06 October 2023. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Australian dividend payers (7.0%). Higher than average of industry peers (0.5%).
공시 • Aug 25Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023Cryosite Limited announced dividend of AUD 0.01500000 per share for the twelve months ended June 30, 2023. Record date is September 8, 2023. Ex-date is September 7, 2023. Payment date is October 6, 2023.
Upcoming Dividend • Sep 08Upcoming dividend of AU$0.01 per shareEligible shareholders must have bought the stock before 15 September 2022. Payment date: 14 October 2022. Trailing yield: 1.4%. Lower than top quartile of Australian dividend payers (6.6%). Higher than average of industry peers (0.4%).
분석 기사 • Jun 01Cryosite (ASX:CTE) Ticks All The Boxes When It Comes To Earnings GrowthFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Reported Earnings • Mar 03First half 2026 earnings released: EPS: AU$0.023 (vs AU$0.017 in 1H 2025)First half 2026 results: EPS: AU$0.023 (up from AU$0.017 in 1H 2025). Revenue: AU$8.27m (up 25% from 1H 2025). Net income: AU$1.14m (up 36% from 1H 2025). Profit margin: 14% (up from 13% in 1H 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.
New Risk • Feb 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 114% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks High level of debt (114% net debt to equity). Market cap is less than US$100m (AU$58.8m market cap, or US$41.9m).
분석 기사 • Feb 09Cryosite Limited's (ASX:CTE) Price Is Out Of Tune With EarningsWith a price-to-earnings (or "P/E") ratio of 31.2x Cryosite Limited ( ASX:CTE ) may be sending very bearish signals at...
Board Change • Jan 13No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Board Change • Dec 11No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improves as stock rises 28%After last week's 28% share price gain to AU$1.30, the stock trades at a trailing P/E ratio of 33.7x. Average trailing P/E is 36x in the Life Sciences industry globally. Total returns to shareholders of 125% over the past three years.
Board Change • Sep 18No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Reported Earnings • Aug 22Full year 2025 earnings released: EPS: AU$0.039 (vs AU$0.038 in FY 2024)Full year 2025 results: EPS: AU$0.039 (up from AU$0.038 in FY 2024). Revenue: AU$14.1m (up 12% from FY 2024). Net income: AU$1.88m (up 2.4% from FY 2024). Profit margin: 13% (down from 15% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
분석 기사 • Aug 19Cryosite Limited's (ASX:CTE) Share Price Could Signal Some RiskASX:CTE 1 Year Share Price vs Fair Value Explore Cryosite's Fair Values from the Community and select yours It's not a...
공시 • Aug 18Cryosite Limited, Annual General Meeting, Oct 16, 2025Cryosite Limited, Annual General Meeting, Oct 16, 2025. Location: at the thomson geer offices, at level 23, rialto south tower, 525 collins street, melbourne vic 3004 Australia
Recent Insider Transactions • Jul 02Non-Executive Chairman recently bought AU$56k worth of stockOn the 27th of June, Mark Kerr bought around 75k shares on-market at roughly AU$0.74 per share. This transaction amounted to 1.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Mark's only on-market trade for the last 12 months.
Board Change • Jun 23No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Board Change • Mar 17No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Reported Earnings • Feb 24First half 2025 earnings released: EPS: AU$0.017 (vs AU$0.017 in 1H 2024)First half 2025 results: EPS: AU$0.017 (in line with 1H 2024). Revenue: AU$6.64m (up 3.7% from 1H 2024). Net income: AU$838.0k (flat on 1H 2024). Profit margin: 13% (in line with 1H 2024). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Jan 15Cryosite Limited's (ASX:CTE) Subdued P/E Might Signal An OpportunityThere wouldn't be many who think Cryosite Limited's ( ASX:CTE ) price-to-earnings (or "P/E") ratio of 19.1x is worth a...
공시 • Nov 22Cryosite Limited Announces Resignation of Michael Austin as Joint Company SecretaryCryosite Limited announced that Mr. Michael Austin has resigned as Joint Company Secretary, effective 22 November 2024. Mr. Hamish George of Bio101 Financial Advisory Pty Ltd. remains as Company Secretary and is responsible for communications with the ASX in relation to Listing Rule matters under ASX Listing Rule 12.6.
공시 • Oct 21Cryosite Limited, Annual General Meeting, Nov 22, 2024Cryosite Limited, Annual General Meeting, Nov 22, 2024. Location: boardroom, level 2 90 william st, melbourne,vic, 3000., melbourne, Australia
공시 • Sep 20Cryosite Limited Announces Company Secretary ChangesCryosite Limited announced that Hamish George and Michael Austin of Bio101 Financial Advisory Pty Ltd. (Bio101) have been appointed Joint Company Secretaries of the Company. The appointment follows the resignation of Mr. Dray Andrea as Company Secretary, effective 20 September 2024. The Board would like to thank Mr. Andrea for his service in the role of Company Secretary.
분석 기사 • Aug 22Cryosite (ASX:CTE) Is Due To Pay A Dividend Of A$0.02Cryosite Limited ( ASX:CTE ) has announced that it will pay a dividend of A$0.02 per share on the 10th of October. This...
Declared Dividend • Aug 22Final dividend of AU$0.02 announcedShareholders will receive a dividend of AU$0.02. Ex-date: 6th September 2024 Payment date: 10th October 2024 Dividend yield will be 8.8%, which is higher than the industry average of 0.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share has grown by 14% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Aug 21Full year 2024 earnings released: EPS: AU$0.038 (vs AU$0.029 in FY 2023)Full year 2024 results: EPS: AU$0.038 (up from AU$0.029 in FY 2023). Revenue: AU$12.6m (up 5.7% from FY 2023). Net income: AU$1.84m (up 31% from FY 2023). Profit margin: 15% (up from 12% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year and the company’s share price has also increased by 22% per year.
분석 기사 • Aug 20With A 31% Price Drop For Cryosite Limited (ASX:CTE) You'll Still Get What You Pay ForCryosite Limited ( ASX:CTE ) shares have had a horrible month, losing 31% after a relatively good period beforehand...
공시 • Aug 20+ 2 more updatesCryosite Limited Announces Retirement of John Hogg as Chief Executive Officer, Effective October 31, 2024Cryosite announced the retirement of its Chief Executive Officer, Mr. John Hogg, with effect from October 31, 2024. The Board thanks Mr. Hogg for his support and service to the Board and the Company over his tenure.
Buy Or Sell Opportunity • Jul 26Now 20% undervaluedOver the last 90 days, the stock has risen 14% to AU$0.97. The fair value is estimated to be AU$1.22, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.5% over the last 3 years. Earnings per share has grown by 29%.
분석 기사 • Jul 23Calculating The Intrinsic Value Of Cryosite Limited (ASX:CTE)Key Insights The projected fair value for Cryosite is AU$1.21 based on 2 Stage Free Cash Flow to Equity With AU$0.98...
New Risk • Jun 26New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: AU$8.2m This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Significant insider selling over the past 3 months (AU$8.2m sold). Market cap is less than US$100m (AU$56.1m market cap, or US$37.5m).
공시 • Jun 25Cryosite Limited Announces Retirement of Andrew Kroger from the Board of DirectorsCryosite Limited announced that Andrew Kroger has retired from the board of directors (Board) effective from June 25, 2024.
Valuation Update With 7 Day Price Move • May 24Investor sentiment improves as stock rises 24%After last week's 24% share price gain to AU$1.05, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 32x in the Life Sciences industry globally. Total returns to shareholders of 238% over the past three years.
분석 기사 • May 09Cryosite Limited's (ASX:CTE) 33% Jump Shows Its Popularity With InvestorsThe Cryosite Limited ( ASX:CTE ) share price has done very well over the last month, posting an excellent gain of 33...
Recent Insider Transactions • Apr 27Non Executive Director recently sold AU$830k worth of stockOn the 23rd of April, Andrew Kroger sold around 1m shares on-market at roughly AU$0.83 per share. This transaction amounted to 7.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
공시 • Feb 22Cryosite Limited Announces Board ChangesCryosite Limited announced the appointment of Mr. Andrew Kerr as a Director of the Company. Mr. John Hogg will step down as Managing Director and continue in his current executive position as CEO of Cryosite. Andrew is an experienced financial services professional in both the Australian and international markets. Andrew is a qualified Certified Practising Accountant (CPA) and a graduate of the Australian Institute of Company Directors (GAICD) course. Through his roles at Bank of America Merrill Lynch and Macquarie Bank, Andrew has obtained strong sustainability and ESG credentials which will greatly complement the Board.
Upcoming Dividend • Feb 14Upcoming dividend of AU$0.05 per share at 2.2% yieldEligible shareholders must have bought the stock before 21 February 2024. Payment date: 29 February 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (0.5%).
분석 기사 • Feb 02Subdued Growth No Barrier To Cryosite Limited's (ASX:CTE) PriceWhen close to half the companies in Australia have price-to-earnings ratios (or "P/E's") below 18x, you may consider...
Board Change • Dec 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Dec 08Cryosite Limited Announces Director ChangesCryosite Limited announced the appointment of Mr. Mark Kerr, as a new Director and Chairman. Mr. John Hogg, CEO of Cryosite will also join the Board as the Managing Director. The only variation to Mr. Hogg's employment agreement is to reflect his new office with the Company. The company announced the retirement from the Board of Directors of Steven Waller, Nicola Swift and Luis Antonio. The Board thanks the three retiring directors for their outstanding contribution to the Company over a number of years. The retiring directors have contributed substantial hours beyond what was expected to ensure the success of the Company going forward.
공시 • Oct 02Cryosite Limited, Annual General Meeting, Nov 23, 2023Cryosite Limited, Annual General Meeting, Nov 23, 2023, at 11:01 AUS Eastern Standard Time. Location: The offices of Cryosite, 13A Ferndell St, South Granville New South Wales Australia
Upcoming Dividend • Aug 31Upcoming dividend of AU$0.015 per share at 1.5% yieldEligible shareholders must have bought the stock before 07 September 2023. Payment date: 06 October 2023. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Australian dividend payers (7.0%). Higher than average of industry peers (0.5%).
공시 • Aug 25Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023Cryosite Limited announced dividend of AUD 0.01500000 per share for the twelve months ended June 30, 2023. Record date is September 8, 2023. Ex-date is September 7, 2023. Payment date is October 6, 2023.
Reported Earnings • Feb 24First half 2023 earnings released: EPS: AU$0.014 (vs AU$0.016 in 1H 2022)First half 2023 results: EPS: AU$0.014 (down from AU$0.016 in 1H 2022). Revenue: AU$5.72m (down 1.7% from 1H 2022). Net income: AU$678.7k (down 13% from 1H 2022). Profit margin: 12% (down from 13% in 1H 2022). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 150% per year, which means it is well ahead of earnings.
분석 기사 • Feb 07Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
공시 • Jan 20Cryosite Limited Announces Change of Company SecretaryCryosite Limited announces the resignation of Kim Bradley-Ware and the appointment of Dray Andrea as Company Secretary, both effective January 18, 2023.
Recent Insider Transactions • Jan 18Insider recently bought AU$481k worth of stockOn the 13th of January, Mark Kerr bought around 650k shares on-market at roughly AU$0.74 per share. This transaction amounted to 39% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$582k. Insiders have collectively bought AU$2.6m more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Dec 26Insider recently bought AU$582k worth of stockOn the 19th of December, Mark Kerr bought around 885k shares on-market at roughly AU$0.66 per share. This transaction amounted to 79% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$2.1m more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Oct 14Insider recently bought AU$447k worth of stockOn the 11th of October, Mark Kerr bought around 600k shares on-market at roughly AU$0.74 per share. This transaction amounted to 63% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$1.6m more in shares than they have sold in the last 12 months.
공시 • Sep 21Cryosite Limited, Annual General Meeting, Nov 17, 2022Cryosite Limited, Annual General Meeting, Nov 17, 2022, at 10:00 E. Australia Standard Time. Location: at the offices of Stone & Chalk, Level 4, 11 York Street, Sydney NSW 2000 Sydney Nsw 2000 Australia
Upcoming Dividend • Sep 08Upcoming dividend of AU$0.01 per shareEligible shareholders must have bought the stock before 15 September 2022. Payment date: 14 October 2022. Trailing yield: 1.4%. Lower than top quartile of Australian dividend payers (6.6%). Higher than average of industry peers (0.4%).
공시 • Aug 26Cryosite Limited Announces Ordinary Dividend for the Year Ended June 30, 2022, Payable on October 14, 2022Cryosite Limited announced ordinary dividend of AUD 0.01000000 for the year ended June 30, 2022. Record Date is September 16, 2022. Ex Date is September 15, 2022. Payment Date is October 14, 2022.
Reported Earnings • Aug 26Full year 2022 earnings released: EPS: AU$0.028 (vs AU$0.014 in FY 2021)Full year 2022 results: EPS: AU$0.028 (up from AU$0.014 in FY 2021). Revenue: AU$11.8m (up 17% from FY 2021). Net income: AU$1.36m (up 109% from FY 2021). Profit margin: 12% (up from 6.5% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 136% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Aug 19Should You Be Adding Cryosite (ASX:CTE) To Your Watchlist Today?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
분석 기사 • May 02Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Mar 03Non Executive Director recently bought AU$321k worth of stockOn the 28th of February, Andrew Kroger bought around 716k shares on-market at roughly AU$0.45 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$931k more in shares than they have sold in the last 12 months.
Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.016 (up from AU$0.006 in 1H 2021). Revenue: AU$5.82m (up 19% from 1H 2021). Net income: AU$782.4k (up 175% from 1H 2021). Profit margin: 13% (up from 5.8% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has increased by 119% per year, which means it is tracking significantly ahead of earnings growth.
Recent Insider Transactions Derivative • Sep 09Key Executive exercised options to buy AU$546k worth of stock.On the 6th of September, Bryan Dulhunty exercised options to buy 1m shares at a strike price of around AU$0.06, costing a total of AU$78k. This transaction amounted to 4,333% of their direct individual holding at the time of the trade. Bryan currently holds less than 1% of total shares outstanding. Company insiders have collectively bought AU$687k more than they sold, via options and on-market transactions, in the last 12 months.
Reported Earnings • Aug 26Full year 2021 earnings released: EPS AU$0.014 (vs AU$0.032 in FY 2020)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: AU$10.1m (up 12% from FY 2020). Net income: AU$652.6k (down 56% from FY 2020). Profit margin: 6.5% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has increased by 91% per year, which means it is tracking significantly ahead of earnings growth.
Recent Insider Transactions • Jun 11Non Executive Director recently bought AU$170k worth of stockOn the 8th of June, Andrew Kroger bought around 473k shares on-market at roughly AU$0.36 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$173k more in shares than they have sold in the last 12 months.
Is New 90 Day High Low • Feb 17New 90-day low: AU$0.21The company is down 25% from its price of AU$0.28 on 18 November 2020. The Australian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is up 11% over the same period.
Is New 90 Day High Low • Dec 21New 90-day high: AU$0.36The company is up 59% from its price of AU$0.23 on 22 September 2020. The Australian market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is down 2.0% over the same period.
Is New 90 Day High Low • Nov 12New 90-day high: AU$0.30The company is up 76% from its price of AU$0.17 on 14 August 2020. The Australian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is down 12% over the same period.
공시 • Oct 15+ 1 more updateCryosite Limited Announces the Appointment of John Hogg as Chief Executive OfficerCryosite Limited announced the appointment of Mr. John Hogg as Chief Executive Officer of the Company commencing October 15, 2020. Mr. Hogg joined Cryosite in July 2018 and was promoted to General Manager of Operations on the December 1, 2019. He has deployed his skills and experience in Australia, Asia and the US. Mr. Hogg has qualifications in materials management, freight management, accounting and computing, including European Senior Logistician (ESLog) certification, and he is a Chartered Member of The Chartered Institute of Logistics and Transport (CMILT).
Is New 90 Day High Low • Oct 08New 90-day high: AU$0.24The company is up 71% from its price of AU$0.14 on 10 July 2020. The Australian market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is down 2.0% over the same period.
Is New 90 Day High Low • Sep 18New 90-day high: AU$0.21The company is up 65% from its price of AU$0.13 on 18 June 2020. The Australian market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Life Sciences industry, which is up 11% over the same period.